Placental fractalkine is up-regulated in severe early-onset preeclampsia.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 4486762)

Published in Am J Pathol on March 11, 2015

Authors

Monika Siwetz1, Martina Dieber-Rotheneder2, Mila Cervar-Zivkovic3, Daniel Kummer1, Julia Kremshofer1, Gregor Weiss1, Florian Herse4, Berthold Huppertz1, Martin Gauster5

Author Affiliations

1: Institute of Cell Biology, Histology and Embryology, Medical University Graz, Graz, Austria.
2: Department of Obstetrics and Gynaecology, Medical University Graz, Graz, Austria; Institute of Pathology, Medical University Graz, Graz, Austria.
3: Department of Obstetrics and Gynaecology, Medical University Graz, Graz, Austria.
4: Experimental and Clinical Research Center, a Joint Cooperation between the Charité Medical Faculty and the Max-Delbrueck Center for Molecular Medicine, Berlin, Germany.
5: Institute of Cell Biology, Histology and Embryology, Medical University Graz, Graz, Austria. Electronic address: martin.gauster@medunigraz.at.

Articles cited by this

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell (1997) 6.70

The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood (2003) 3.51

Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol (1998) 3.37

Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem (2001) 2.91

Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int (2007) 2.87

Placental origins of preeclampsia: challenging the current hypothesis. Hypertension (2008) 2.62

Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol (1997) 2.46

Inflammation and pre-eclampsia. Semin Fetal Neonatal Med (2006) 2.28

Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol (2003) 1.80

Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta (2005) 1.62

Spatial and temporal dynamics of the endothelium. J Thromb Haemost (2005) 1.51

Aspirin inhibits fractalkine expression in atherosclerotic plaques and reduces atherosclerosis in ApoE gene knockout mice. Cardiovasc Drugs Ther (2010) 1.51

The placenta cytokine network and inflammatory signals. Placenta (2005) 1.46

Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J Immunol (2007) 1.32

The effect of sodium salicylate and aspirin on NF-kappa B. Science (1995) 1.31

Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol (2007) 1.26

Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia. J Matern Fetal Neonatal Med (2010) 1.23

Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol (2012) 1.18

Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. Expert Opin Ther Targets (2010) 1.17

Activation of leukocytes during the uteroplacental passage in preeclampsia. Hypertension (2002) 1.17

Transmembrane chemokines: versatile 'special agents' in vascular inflammation. Thromb Haemost (2007) 1.16

Aspirin and salicylate: An old remedy with a new twist. Circulation (2000) 1.15

Fractalkine/CX3CL1: a potential new target for inflammatory diseases. Mol Interv (2010) 1.14

The chemokines, CX3CL1, CCL14, and CCL4, promote human trophoblast migration at the feto-maternal interface. Biol Reprod (2006) 1.13

Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. Am J Reprod Immunol (2013) 1.10

Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol (1997) 1.08

Association of maternal serum CRP, IL-6, TNF-alpha, homocysteine, folic acid and vitamin B12 levels with the severity of preeclampsia and fetal birth weight. Hypertens Pregnancy (2009) 1.07

Increased levels of cytokines and cytokine activity modifiers in normal pregnancy. Eur J Obstet Gynecol Reprod Biol (1994) 1.01

Proteases and sFlt-1 release in the human placenta. Placenta (2010) 1.00

Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression. Am J Pathol (2004) 1.00

Tumor necrosis factor stimulates matrix metalloproteinase 9 secretion from cultured human chorionic trophoblast cells through TNF receptor 1 signaling to IKBKB-NFKB and MAPK1/3 pathway. Biol Reprod (2010) 0.99

Glucocorticoid suppression of CX3CL1 (fractalkine) by reduced gene promoter recruitment of NF-kappaB. FASEB J (2008) 0.98

CX3CL1 and CCL14 regulate extracellular matrix and adhesion molecules in the trophoblast: potential roles in human embryo implantation. Biol Reprod (2008) 0.98

TNFalpha-mediated induction of PAI-1 restricts invasion of HTR-8/SVneo trophoblast cells. Placenta (2005) 0.94

Severe preeclampsia goes along with a cytokine network disturbance towards a systemic inflammatory state. Cytokine (2013) 0.94

Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can (2009) 0.92

Peoniflorin suppresses tumor necrosis factor-α induced chemokine production in human dermal microvascular endothelial cells by blocking nuclear factor-κB and ERK pathway. Arch Dermatol Res (2010) 0.91

Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules. Biochim Biophys Acta (2011) 0.90

Identification of differentially regulated genes during elongation and early implantation in the ovine trophoblast using complementary DNA array screening. Biol Reprod (2004) 0.89

CX3CL1 (fractalkine) and TNFα production by perfused human placental lobules under normoxic and hypoxic conditions in vitro: the importance of CX3CR1 signaling. Inflamm Res (2013) 0.85

IL-6, TNFalpha and TGFbeta promote nonapoptotic trophoblast deportation and subsequently causes endothelial cell activation. Placenta (2009) 0.85

Substituted 7-amino-5-thio-thiazolo[4,5-d]pyrimidines as potent and selective antagonists of the fractalkine receptor (CX3CR1). J Med Chem (2013) 0.85

Fractalkine (CX3CL1) and its receptor CX3CR1 may contribute to increased angiogenesis in diabetic placenta. Mediators Inflamm (2013) 0.85

Self-control of HGF regulation on human trophoblast cell invasion via enhancing c-Met receptor shedding by ADAM10 and ADAM17. J Clin Endocrinol Metab (2012) 0.85

Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis. Proc Natl Acad Sci U S A (2014) 0.85

Differential levels of T helper cytokines in preeclampsia: pregnancy, labor and puerperium. Acta Obstet Gynecol Scand (1999) 0.82

Search for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia: the ECLAXIR study. PLoS One (2009) 0.82

Chorioamnionitis (ChA) modifies CX3CL1 (fractalkine) production by human amniotic epithelial cells (HAEC) under normoxic and hypoxic conditions. J Inflamm (Lond) (2014) 0.81

Aspirin inhibits tumor necrosis factor-alpha-stimulated fractalkine expression in human umbilical vein endothelial cells. Chin Med J (Engl) (2009) 0.81

Metalloprotease dependent release of placenta derived fractalkine. Mediators Inflamm (2014) 0.79